Data Sharing Agreement vs Letter of Access (biocides and PPP)
A Data Sharing Agreement (DSA) is the private contract that sets who may use which studies, for what purpose, and at what price. A Letter of Access (LoA) is the formal letter submitted to authorities so the beneficiary can cite those studies. You often need both. The DSA is usually not filed with ECHA; the LoA is.
In one sentence each: NDA: stop confidential information leaking during the first talks. DSA (short form): two parties, existing data, compensation, then an LoA. DSA (long form) / multi-party DSCA: task force or consortium: study list, cost shares, who may issue LoAs. LoA: the citation right the authority actually reads (BPR, PPPR or REACH).
Typical order: NDA, then optional Letter of Intent, then DSA or compensation agreement, then LoA, then submission in R4BP 3, to the Member State, or via REACH-IT. Mixing them in one Word file is how scope, payment and citation rights get confused, and how later versions diverge.
What AlexSignum has live?
EU workspace, live today: LoA: BPR active substance; BPR product / family; PPPR active substance; PPPR product; REACH substance. DSA short form; DSA long form / multi-party DSCA. NDA; Letter of Intent; Data Owner Declaration.
Coming soon: task-force / consortium agreements and compensation-only forms.
Cases are pre-filled. Review is optional. Parties sign by email. After signature the record cannot be altered. Both parties keep the same copy. Anyone can check it has not been tampered with.
Back to What is AlexSignum: https://www.allianceregulatory.com/what-is-alexsignum
Open workspace: https://alexsignum.com/
Contact: contact@allianceregulatory.com